SWITCH TO MULTIPLE DAILY INJECTIONS WITH INSULIN GLARGINE AND INSULIN LISPRO FROM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION WITH INSULIN LISPRO: A RANDOMIZED, OPEN-LABEL STUDY USING A CONTINUOUS GLUCOSE MONITORING SYSTEM

Bruce W. Bode; R. Dennis Steed; Debra S. Schleusener; Poul Strange

doi:10.4158/ep.11.3.157

SWITCH TO MULTIPLE DAILY INJECTIONS WITH INSULIN GLARGINE AND INSULIN LISPRO FROM CONTINUOUS SUBCUTANEOUS INSULIN INFUSION WITH INSULIN LISPRO: A RANDOMIZED, OPEN-LABEL STUDY USING A CONTINUOUS GLUCOSE MONITORING SYSTEM

Endocrine Practice ◽

10.4158/ep.11.3.157 ◽

2005 ◽

Vol 11 (3) ◽

pp. 157-164 ◽

Cited By ~ 16

Author(s):

Bruce W. Bode ◽

R. Dennis Steed ◽

Debra S. Schleusener ◽

Poul Strange

Keyword(s):

Insulin Glargine ◽

Monitoring System ◽

Insulin Lispro ◽

Continuous Subcutaneous Insulin Infusion ◽

Insulin Infusion ◽

Glucose Monitoring ◽

Subcutaneous Insulin ◽

Open Label ◽

Open Label Study ◽

Label Study

Download Full-text

Assessing glycaemic variability with continuous glucose monitoring system before and after continuous subcutaneous insulin infusion in people with Type 1 diabetes

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2010.08.016 ◽

2010 ◽

Vol 90 (3) ◽

pp. e57-e59 ◽

Cited By ~ 6

Author(s):

Elisa Moya Chimenti ◽

Lucrecia Herranz de la Morena ◽

Pilar Martín Vaquero ◽

Lourdes Sáez-de-ibarra ◽

María García Domínguez ◽

...

Keyword(s):

Type 1 Diabetes ◽

Monitoring System ◽

Continuous Glucose Monitoring ◽

Continuous Subcutaneous Insulin Infusion ◽

Insulin Infusion ◽

Glucose Monitoring ◽

Subcutaneous Insulin ◽

Glycaemic Variability ◽

Before And After

Download Full-text

A morning dose of insulin glargine prevents nocturnal ketosis after postprandial interruption of continuous subcutaneous insulin infusion with insulin lispro

Diabetes & Metabolism ◽

10.1016/j.diabet.2007.06.005 ◽

2007 ◽

Vol 33 (6) ◽

pp. 469-471 ◽

Cited By ~ 3

Author(s):

U.B. Johansson ◽

R. Wredling ◽

U. Adamson ◽

P.E. Lins

Keyword(s):

Insulin Glargine ◽

Insulin Lispro ◽

Continuous Subcutaneous Insulin Infusion ◽

Insulin Infusion ◽

Subcutaneous Insulin ◽

Morning Dose

Download Full-text

Comparison of continuous subcutaneous insulin infusion and insulin glargine-based multiple daily insulin aspart injections with preferential adjustment of basal insulin in patients with type 2 diabetes

Experimental and Therapeutic Medicine ◽

10.3892/etm.2014.1866 ◽

2014 ◽

Vol 8 (4) ◽

pp. 1191-1196 ◽

Cited By ~ 5

Author(s):

GUAN-QI GAO ◽

XUE-YUAN HENG ◽

YUE-LI WANG ◽

WEN-XIA LI ◽

QING-YU DONG ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Insulin Aspart ◽

Basal Insulin ◽

Continuous Subcutaneous Insulin Infusion ◽

Insulin Infusion ◽

Subcutaneous Insulin ◽

Daily Insulin

Download Full-text

Epidemiological characterization of diabetic patients on therapy with continuous subcutaneous insulin infusion and continuous glucose monitoring in real time

Endocrinología y Nutrición (English Edition) ◽

10.1016/j.endoen.2015.11.006 ◽

2015 ◽

Vol 62 (9) ◽

pp. 451-457

Author(s):

Natalia Aristizábal ◽

Alex Ramírez ◽

Jaime Hincapié-García ◽

Estefany Laiton ◽

Carolina Aristizábal ◽

...

Keyword(s):

Real Time ◽

Continuous Glucose Monitoring ◽

Continuous Subcutaneous Insulin Infusion ◽

Insulin Infusion ◽

Glucose Monitoring ◽

Diabetic Patients ◽

Subcutaneous Insulin ◽

Epidemiological Characterization

Download Full-text

Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study. Reply to Chantelau E [letter] and Currie CJ [letter]

Diabetologia ◽

10.1007/s00125-009-1492-7 ◽

2009 ◽

Vol 52 (10) ◽

pp. 2236-2239

Author(s):

J. Rosenstock ◽

V. Fonseca ◽

J. B. McGill ◽

M. Riddle ◽

J.-P. Hallé ◽

...

Keyword(s):

Type 2 Diabetes ◽

Diabetic Retinopathy ◽

Insulin Glargine ◽

Open Label ◽

Nph Insulin ◽

Open Label Study ◽

Label Study ◽

Neutral Protamine Hagedorn

Download Full-text

Is It Time for a Revolution? The Role of Continuous Subcutaneous Insulin Infusion and Continuous Glucose Monitoring in Improving Care of Patients With Type 1 Diabetes Mellitus—Introduction

Endocrine Practice ◽

10.4158/ep12245.or ◽

2012 ◽

Vol 18 (Supplement 2) ◽

pp. 7-9

Author(s):

George Grunberger

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Type 1 Diabetes Mellitus ◽

Continuous Glucose Monitoring ◽

Continuous Subcutaneous Insulin Infusion ◽

Insulin Infusion ◽

Glucose Monitoring ◽

Subcutaneous Insulin

Download Full-text

Review for "Impact of Technology on Glycemic Control in Type 2 Diabetes: A Meta‐Analysis of Randomized Trials on Continuous Glucose Monitoring and Continuous Subcutaneous Insulin Infusion"

10.1111/dom.13845/v2/review2 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Continuous Subcutaneous Insulin Infusion ◽

Randomized Trials ◽

Insulin Infusion ◽

Meta Analysis ◽

Glucose Monitoring ◽

Subcutaneous Insulin ◽

Impact Of Technology

Download Full-text

Decision letter for "Impact of Technology on Glycemic Control in Type 2 Diabetes: A Meta‐Analysis of Randomized Trials on Continuous Glucose Monitoring and Continuous Subcutaneous Insulin Infusion"

10.1111/dom.13845/v2/decision1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Continuous Subcutaneous Insulin Infusion ◽

Randomized Trials ◽

Insulin Infusion ◽

Meta Analysis ◽

Glucose Monitoring ◽

Subcutaneous Insulin ◽

Impact Of Technology

Download Full-text

Review for "Impact of Technology on Glycemic Control in Type 2 Diabetes: A Meta‐Analysis of Randomized Trials on Continuous Glucose Monitoring and Continuous Subcutaneous Insulin Infusion"

10.1111/dom.13845/v1/review1 ◽

2019 ◽

Author(s):

Robert Vigersky

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Continuous Subcutaneous Insulin Infusion ◽

Randomized Trials ◽

Insulin Infusion ◽

Meta Analysis ◽

Glucose Monitoring ◽

Subcutaneous Insulin ◽

Impact Of Technology

Download Full-text

Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study

Diabetologia ◽

10.1007/s00125-009-1452-2 ◽

2009 ◽

Vol 52 (9) ◽

pp. 1971-1973 ◽

Cited By ~ 92

Author(s):

J. Rosenstock ◽

V. Fonseca ◽

J. B. McGill ◽

M. Riddle ◽

J. P. Hallé ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Open Label ◽

Nph Insulin ◽

Open Label Study ◽

Label Study ◽

Risk Of Malignancy ◽

Neutral Protamine Hagedorn ◽

Similar Risk

Download Full-text